Detecting Pharmacy Fraud: Is Your Brand’s Co-Pay Program Protected?Kevin Brasco2021-03-07T06:41:56-05:00
Detecting Pharmacy Fraud:
Is Your Brand’s Co-Pay Program Protected?
Matthew Turner, PMP, CSSBB, Director of Product Management
Landy Townsend, Senior Director of Marketing
The incidences of pharmacy fraud involving pharmaceutical manufacturers’ co-pay card programs are on the rise.
In this white paper, TrialCard discusses the steps it has taken to expand its Pharmacy Fraud Monitoring service, which identifies fraud and greatly reduces the reimbursement funds that make it back to the pharmacies in question. This approach has delivered proven results to TrialCard’s pharmaceutical clients and has saved brands valuable reimbursement dollars that otherwise would have been lost.
Please submit the form below to view this resource.